VIRIDIAN THERAPEUTICS INC's ticker is VRDN and the CUSIP is 92790C104. A total of 90 filers reported holding VIRIDIAN THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $214,284 | -97.6% | 13,969 | -95.4% | 0.00% | -100.0% |
| Q4 2022 | $8,895,964 | +155.9% | 304,552 | +79.6% | 0.02% | +118.2% |
| Q3 2022 | $3,477,000 | +1055.1% | 169,529 | +939.9% | 0.01% | +1000.0% |
| Q1 2022 | $301,000 | -86.2% | 16,303 | -86.4% | 0.00% | -90.0% |
| Q2 2021 | $2,185,000 | +9.4% | 119,478 | -0.1% | 0.01% | 0.0% |
| Q1 2021 | $1,998,000 | – | 119,576 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ally Bridge Group (NY) LLC | 680,768 | $11,376,000 | 2.18% |
| COMMODORE CAPITAL LP | 185,781 | $3,104,000 | 1.24% |
| Ghost Tree Capital, LLC | 300,000 | $5,013,000 | 1.18% |
| Logos Global Management LP | 550,000 | $9,191,000 | 0.90% |
| Atlas Venture Advisors, Inc. | 209,505 | $3,501,000 | 0.65% |
| BVF INC/IL | 463,504 | $7,745,000 | 0.29% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 27,586 | $461,000 | 0.25% |
| Fairmount Funds Management LLC | 35,092 | $581,000 | 0.24% |
| Soleus Capital Management, L.P. | 67,685 | $1,131,000 | 0.20% |
| Cormorant Asset Management, LP | 459,144 | $7,672,000 | 0.17% |